Previous close | 35.59 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 681 |
Market cap | 21.231M |
Beta (5Y monthly) | 1.13 |
PE ratio (TTM) | 4.21 |
EPS (TTM) | 0.09 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SAN DIEGO, April 29, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:
Key Insights Tandem Diabetes Care's estimated fair value is US$50.92 based on 2 Stage Free Cash Flow to Equity Tandem...
Tandem Diabetes Care (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.